An Open-label Safety, Efficacy and Pharmacokinetic Study of a Recombinant FVIII Compared to Recombinant Human Antihemophilic FVIII in Patients With Severe Hemophilia A
Clinical trial NCT01486927 · COMPLETED
Trial details
- NCT number
- NCT01486927
- Sponsor
- CSL Behring
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2014-12-01
- Enrollment
- 175
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.